Jan 13 2025 12 mins
Visit https://www.peervoice.com/TJF860 to view the entire programme with slides. After completing “Rachel Goodwin, MD, MSc, FRCPC - Improving Care for Advanced Colorectal Cancer With Later-Line Treatments”, participants will be able to: Outline current treatment recommendations for the management of refractory metastatic colorectal cancer (mCRC); Analyze the clinical evidence of approved and emerging treatments for late-stage refractory mCRC; and Discuss the implications of the data for treatment selection, sequencing, and timely switching for patients with refractory mCRC.